Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Adams, H. P.
Right arrow Articles by Goldberg, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Adams, H. P., Jr
Right arrow Articles by Goldberg, M.

Stroke, Vol 17, 404-409, Copyright © 1986 by American Heart Association


ARTICLES

A dose-escalation study of large doses of naloxone for treatment of patients with acute cerebral ischemia

HP Adams Jr, CP Olinger, WG Barsan, MJ Butler, NR Graff-Radford, TG Brott, J Biller, H Damasio, T Tomsick and M Goldberg

A dose-escalation study was performed in 27 patients to determine the highest safe and potentially optimal dose of naloxone for treatment of acute cerebral ischemia. All patients received a bolus of naloxone followed by a continuous 24 hour infusion at an hourly rate 50% of the bolus. Loading doses ranged from 2.5 to 200 mg/m2. Total patient doses ranged from 52.3 to 4978 mg. No major dose-related side effects occurred. This study was not designed to determine naloxone's efficacy in stroke, but transient or sustained improvement was observed in 13 patients. Three patients' neurological condition worsened within three hours after the naloxone was discontinued. Our experience suggests that further therapeutic trials of naloxone are worthwhile.


This article has been cited by other articles:


Home page
Arch NeurolHome page
L. B. Goldstein, C. Bertels, and J. N. Davis
Interrater Reliability of the NIH Stroke Scale
Arch Neurol, June 1, 1989; 46(6): 660 - 662.
[Abstract] [PDF]


Home page
J Intensive Care MedHome page
L. R. Wechsler
Analytic Reviews : Potential New Therapies for Acute Ischemic Stroke
J Intensive Care Med, September 1, 1988; 3(5): 258 - 264.
[Abstract] [PDF]


Home page
Arch NeurolHome page
M. A. Sloan
Thrombolysis and Stroke: Past and Future
Arch Neurol, July 1, 1987; 44(7): 748 - 768.
[Abstract] [PDF]